VAREX IMAGING CORP (VREX) Fundamental Analysis & Valuation

NASDAQ:VREX • US92214X1063

Current stock price

10.73 USD
-0.05 (-0.46%)
At close:
10.73 USD
0 (0%)
After Hours:

This VREX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. VREX Profitability Analysis

1.1 Basic Checks

  • In the past year VREX was profitable.
  • VREX had a positive operating cash flow in the past year.
  • In multiple years VREX reported negative net income over the last 5 years.
  • In the past 5 years VREX always reported a positive cash flow from operatings.
VREX Yearly Net Income VS EBIT VS OCF VS FCFVREX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M

1.2 Ratios

  • VREX's Return On Assets of -6.17% is fine compared to the rest of the industry. VREX outperforms 67.72% of its industry peers.
  • VREX's Return On Equity of -14.20% is fine compared to the rest of the industry. VREX outperforms 65.08% of its industry peers.
  • VREX has a Return On Invested Capital of 5.94%. This is in the better half of the industry: VREX outperforms 78.84% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for VREX is below the industry average of 9.31%.
  • The last Return On Invested Capital (5.94%) for VREX is above the 3 year average (4.82%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -6.17%
ROE -14.2%
ROIC 5.94%
ROA(3y)-2.14%
ROA(5y)-0.47%
ROE(3y)-5.1%
ROE(5y)-1.2%
ROIC(3y)4.82%
ROIC(5y)5.54%
VREX Yearly ROA, ROE, ROICVREX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10

1.3 Margins

  • Looking at the Operating Margin, with a value of 8.23%, VREX is in the better half of the industry, outperforming 75.13% of the companies in the same industry.
  • VREX's Operating Margin has declined in the last couple of years.
  • VREX's Gross Margin of 34.15% is on the low side compared to the rest of the industry. VREX is outperformed by 71.96% of its industry peers.
  • VREX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.23%
PM (TTM) N/A
GM 34.15%
OM growth 3Y-8.19%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5Y5.76%
VREX Yearly Profit, Operating, Gross MarginsVREX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. VREX Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VREX is destroying value.
  • VREX has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for VREX has been increased compared to 5 years ago.
  • VREX has a better debt/assets ratio than last year.
VREX Yearly Shares OutstandingVREX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
VREX Yearly Total Debt VS Total AssetsVREX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 1.93 indicates that VREX is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of VREX (1.93) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.78 indicates that VREX is somewhat dependend on debt financing.
  • The Debt to Equity ratio of VREX (0.78) is worse than 68.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Altman-Z 1.93
ROIC/WACC0.55
WACC10.76%
VREX Yearly LT Debt VS Equity VS FCFVREX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M 500M

2.3 Liquidity

  • A Current Ratio of 3.89 indicates that VREX has no problem at all paying its short term obligations.
  • VREX has a Current ratio of 3.89. This is in the better half of the industry: VREX outperforms 64.55% of its industry peers.
  • VREX has a Quick Ratio of 1.87. This is a normal value and indicates that VREX is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.87, VREX is in line with its industry, outperforming 48.68% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.89
Quick Ratio 1.87
VREX Yearly Current Assets VS Current LiabilitesVREX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. VREX Growth Analysis

3.1 Past

  • VREX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 78.57%, which is quite impressive.
  • The Earnings Per Share has been growing by 57.78% on average over the past years. This is a very strong growth
  • The Revenue has been growing slightly by 4.09% in the past year.
  • VREX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.73% yearly.
EPS 1Y (TTM)78.57%
EPS 3Y-14.54%
EPS 5Y57.78%
EPS Q2Q%171.43%
Revenue 1Y (TTM)4.09%
Revenue growth 3Y-0.58%
Revenue growth 5Y2.73%
Sales Q2Q%4.9%

3.2 Future

  • Based on estimates for the next years, VREX will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.31% on average per year.
  • The Revenue is expected to grow by 5.15% on average over the next years.
EPS Next Y3.8%
EPS Next 2Y8.68%
EPS Next 3Y14.64%
EPS Next 5Y18.31%
Revenue Next Year4.48%
Revenue Next 2Y4.18%
Revenue Next 3Y4.62%
Revenue Next 5Y5.15%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
VREX Yearly Revenue VS EstimatesVREX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
VREX Yearly EPS VS EstimatesVREX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

5

4. VREX Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 10.73 indicates a reasonable valuation of VREX.
  • Compared to the rest of the industry, the Price/Earnings ratio of VREX indicates a rather cheap valuation: VREX is cheaper than 91.53% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 24.89. VREX is valued rather cheaply when compared to this.
  • A Price/Forward Earnings ratio of 10.32 indicates a reasonable valuation of VREX.
  • 93.12% of the companies in the same industry are more expensive than VREX, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of VREX to the average of the S&P500 Index (22.19), we can say VREX is valued rather cheaply.
Industry RankSector Rank
PE 10.73
Fwd PE 10.32
VREX Price Earnings VS Forward Price EarningsVREX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, VREX is valued cheaply inside the industry as 96.30% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.11
VREX Per share dataVREX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates VREX does not grow enough to justify the current Price/Earnings ratio.
  • VREX's earnings are expected to grow with 14.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.83
PEG (5Y)0.19
EPS Next 2Y8.68%
EPS Next 3Y14.64%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. VREX Dividend Analysis

5.1 Amount

  • VREX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VREX Fundamentals: All Metrics, Ratios and Statistics

VAREX IMAGING CORP

NASDAQ:VREX (3/27/2026, 8:00:01 PM)

After market: 10.73 0 (0%)

10.73

-0.05 (-0.46%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-10
Earnings (Next)05-06
Inst Owners98.54%
Inst Owner Change3.93%
Ins Owners1.58%
Ins Owner Change14.9%
Market Cap449.59M
Revenue(TTM)854.40M
Net Income(TTM)-67.70M
Analysts83.64
Price Target19.18 (78.75%)
Short Float %2.85%
Short Ratio3.37
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)69.41%
Min EPS beat(2)40.06%
Max EPS beat(2)98.76%
EPS beat(4)4
Avg EPS beat(4)156.06%
Min EPS beat(4)40.06%
Max EPS beat(4)404.2%
EPS beat(8)6
Avg EPS beat(8)96.39%
EPS beat(12)9
Avg EPS beat(12)67.16%
EPS beat(16)13
Avg EPS beat(16)58.24%
Revenue beat(2)1
Avg Revenue beat(2)0.64%
Min Revenue beat(2)-1.06%
Max Revenue beat(2)2.35%
Revenue beat(4)3
Avg Revenue beat(4)1.84%
Min Revenue beat(4)-1.06%
Max Revenue beat(4)4.57%
Revenue beat(8)4
Avg Revenue beat(8)0.23%
Revenue beat(12)5
Avg Revenue beat(12)0.05%
Revenue beat(16)8
Avg Revenue beat(16)0.29%
PT rev (1m)0%
PT rev (3m)9.3%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.88%
EPS NY rev (1m)5.14%
EPS NY rev (3m)4.13%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.11%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.54%
Valuation
Industry RankSector Rank
PE 10.73
Fwd PE 10.32
P/S 0.53
P/FCF N/A
P/OCF 27.92
P/B 0.94
P/tB 1.7
EV/EBITDA 7.11
EPS(TTM)1
EY9.32%
EPS(NY)1.04
Fwd EY9.69%
FCF(TTM)-0.32
FCFYN/A
OCF(TTM)0.38
OCFY3.58%
SpS20.39
BVpS11.38
TBVpS6.3
PEG (NY)2.83
PEG (5Y)0.19
Graham Number16
Profitability
Industry RankSector Rank
ROA -6.17%
ROE -14.2%
ROCE 7.52%
ROIC 5.94%
ROICexc 6.86%
ROICexgc 9.31%
OM 8.23%
PM (TTM) N/A
GM 34.15%
FCFM N/A
ROA(3y)-2.14%
ROA(5y)-0.47%
ROE(3y)-5.1%
ROE(5y)-1.2%
ROIC(3y)4.82%
ROIC(5y)5.54%
ROICexc(3y)5.86%
ROICexc(5y)6.54%
ROICexgc(3y)8.71%
ROICexgc(5y)10.09%
ROCE(3y)6.1%
ROCE(5y)7.01%
ROICexgc growth 3Y-6.75%
ROICexgc growth 5YN/A
ROICexc growth 3Y-3.38%
ROICexc growth 5YN/A
OM growth 3Y-8.19%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5Y5.76%
F-Score5
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Debt/EBITDA 3.82
Cap/Depr 109.29%
Cap/Sales 3.44%
Interest Coverage 2.18
Cash Conversion 16.56%
Profit Quality N/A
Current Ratio 3.89
Quick Ratio 1.87
Altman-Z 1.93
F-Score5
WACC10.76%
ROIC/WACC0.55
Cap/Depr(3y)77.68%
Cap/Depr(5y)67.38%
Cap/Sales(3y)2.78%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.57%
EPS 3Y-14.54%
EPS 5Y57.78%
EPS Q2Q%171.43%
EPS Next Y3.8%
EPS Next 2Y8.68%
EPS Next 3Y14.64%
EPS Next 5Y18.31%
Revenue 1Y (TTM)4.09%
Revenue growth 3Y-0.58%
Revenue growth 5Y2.73%
Sales Q2Q%4.9%
Revenue Next Year4.48%
Revenue Next 2Y4.18%
Revenue Next 3Y4.62%
Revenue Next 5Y5.15%
EBIT growth 1Y79.34%
EBIT growth 3Y-8.72%
EBIT growth 5YN/A
EBIT Next Year53.33%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-113.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-86.85%
OCF growth 3Y35.13%
OCF growth 5Y25.87%

VAREX IMAGING CORP / VREX Fundamental Analysis FAQ

What is the fundamental rating for VREX stock?

ChartMill assigns a fundamental rating of 4 / 10 to VREX.


What is the valuation status of VAREX IMAGING CORP (VREX) stock?

ChartMill assigns a valuation rating of 5 / 10 to VAREX IMAGING CORP (VREX). This can be considered as Fairly Valued.


What is the profitability of VREX stock?

VAREX IMAGING CORP (VREX) has a profitability rating of 5 / 10.


How financially healthy is VAREX IMAGING CORP?

The financial health rating of VAREX IMAGING CORP (VREX) is 3 / 10.


What is the expected EPS growth for VAREX IMAGING CORP (VREX) stock?

The Earnings per Share (EPS) of VAREX IMAGING CORP (VREX) is expected to grow by 3.8% in the next year.